Last checked at 10 Jan 2022 07:00
10 January 2022
Assura plc
Scrip Dividend Declaration
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 12 January 2022 (the "Scrip Dividend Alternative"), elections were received in respect of 10 per cent. of the Company's ordinary shares in issue as at the record date of 10 December 2021.
Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 3,286,937 Shares (the "New Shares") will be issued by the Company to such shareholders.
Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 12 January 2022.
Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,948,359,637 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,948,359,637.
Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).
This interim dividend is 100% Ordinary Dividend (non-PID).
Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.
- ENDS -
For more information, please contact:
Assura plc |
Tel: 01925 420680 |
Orla Ball, Company Secretary David Purcell, Head of Investor Relations
| Email: Investor@assura.co.uk |
Finsbury Gordon SimpsonJames Thompson | Tel: 0207 251 3801 Email: Assura@Finsbury.com |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at £2,595 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72